UK government trials weight-loss injections for unemployed to boost productivity and reduce NHS costs.

The UK government plans to trial weight-loss injections, like Ozempic and Mounjaro, for unemployed individuals to aid their return to work and reduce pressure on the NHS. Funded by a £279 million investment from Eli Lilly, the Greater Manchester study will assess the jabs' impact on productivity and healthcare costs, addressing the obesity crisis linked to increased sick days and rising NHS expenses. The initiative emphasizes personal responsibility for health.

October 14, 2024
170 Articles